1. Home
  2. REPL vs SFIX Comparison

REPL vs SFIX Comparison

Compare REPL & SFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REPL
  • SFIX
  • Stock Information
  • Founded
  • REPL 2015
  • SFIX 2011
  • Country
  • REPL United States
  • SFIX United States
  • Employees
  • REPL N/A
  • SFIX N/A
  • Industry
  • REPL Biotechnology: Pharmaceutical Preparations
  • SFIX Catalog/Specialty Distribution
  • Sector
  • REPL Health Care
  • SFIX Consumer Discretionary
  • Exchange
  • REPL Nasdaq
  • SFIX Nasdaq
  • Market Cap
  • REPL 547.0M
  • SFIX 583.4M
  • IPO Year
  • REPL 2018
  • SFIX 2017
  • Fundamental
  • Price
  • REPL $9.42
  • SFIX $4.20
  • Analyst Decision
  • REPL Buy
  • SFIX Hold
  • Analyst Count
  • REPL 9
  • SFIX 5
  • Target Price
  • REPL $12.00
  • SFIX $5.75
  • AVG Volume (30 Days)
  • REPL 2.6M
  • SFIX 2.1M
  • Earning Date
  • REPL 11-06-2025
  • SFIX 12-04-2025
  • Dividend Yield
  • REPL N/A
  • SFIX N/A
  • EPS Growth
  • REPL N/A
  • SFIX N/A
  • EPS
  • REPL N/A
  • SFIX N/A
  • Revenue
  • REPL N/A
  • SFIX $1,267,171,000.00
  • Revenue This Year
  • REPL N/A
  • SFIX $4.88
  • Revenue Next Year
  • REPL N/A
  • SFIX $3.91
  • P/E Ratio
  • REPL N/A
  • SFIX N/A
  • Revenue Growth
  • REPL N/A
  • SFIX N/A
  • 52 Week Low
  • REPL $2.68
  • SFIX $2.60
  • 52 Week High
  • REPL $17.00
  • SFIX $6.99
  • Technical
  • Relative Strength Index (RSI)
  • REPL 62.38
  • SFIX 46.07
  • Support Level
  • REPL $8.50
  • SFIX $3.97
  • Resistance Level
  • REPL $9.30
  • SFIX $4.55
  • Average True Range (ATR)
  • REPL 0.61
  • SFIX 0.22
  • MACD
  • REPL -0.14
  • SFIX -0.00
  • Stochastic Oscillator
  • REPL 75.95
  • SFIX 36.21

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

About SFIX Stitch Fix Inc.

Stitch Fix Inc offers personal style services for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandise with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types, and price points including Women's, Petite, Maternity, Men's, and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry, and handbags and sells merchandise across various ranges of price points.

Share on Social Networks: